United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

11:35am EDT
Change (% chg)

€0.46 (+0.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)


Beta: 0.37
Market Cap(Mil.): €25,119.78
Shares Outstanding(Mil.): 307.95
Dividend: 0.96
Yield (%): 1.18


  Industry Sector
P/E (TTM): -- 29.84 16.08
EPS (TTM): -- -- --
ROI: -- 6.64 14.60
ROE: -- 10.48 14.03

BRIEF-Eurotech wins order from Fresenius Medical Care for IoT project​


Sep 08 2017

Fresenius asks court to toss 10 suits from dialysis MDL

Fresenius Medical Care has asked a federal judge in Massachusetts to grant it summary judgment in 10 lawsuits by individuals who claimed the death of a family member was caused by the company's dialysis products, arguing a March jury verdict cleared it of liability.

Aug 24 2017

BRIEF-NxStage Medical says if merger terminated, Fresenius Medical Care Holdings to pay termination fee of $100 mln- SEC Filing

* NxStage Medical - if merger agreement terminated under certain circumstances,Fresenius Medical Care Holdings to pay co a termination fee of $100 million Source text: (http://bit.ly/2ujNeVi) Further company coverage:

Aug 07 2017

Deals of the day-Mergers and acquisitions

Aug 7 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Aug 07 2017

Fresenius Medical banks on home dialysis with $2 billion NxStage acquisition

FRANKFURT Germany's Fresenius Medical Care (FMC) has struck a $2 billion deal to acquire U.S. home dialysis equipment maker NxStage Medical Inc , looking to capitalize on a trend for more patients to opt for domestic treatment.

Aug 07 2017

UPDATE 1-Dialysis provider FMC's Q2 profit misses consensus as costs weigh

* Profit at parent Fresenius jumps on new drug launches (Adds company comment on costs, premarket shares, parent Fresenius)

Aug 01 2017

Dialysis provider FMC's Q2 profit edges up 2 pct as costs weigh

FRANKFURT, Aug 1 Fresenius Medical Care , the world's largest provider of kidney dialysis, posted a 2 percent gain in quarterly operating profit, missing consensus, as growth in the number of dialysis patients was offset by higher personnel expenses and other costs.

Aug 01 2017

Fresenius Medical launches cost savings programme

FRANKFURT, June 8 German kidney dialysis specialist Fresenius Medical Care on Thursday said it was targeting up to 200 million euros ($225 million) in annual cost savings from 2020 as part of a new efficiency drive.

Jun 08 2017

Fitch Rates Fresenius Medical Care Bonds 'BBB-'

(The following statement was released by the rating agency) LONDON, May 25 (Fitch) Fitch Ratings has assigned senior unsecured ratings of 'BBB-' to debt instruments issued by the various finance companies of Fresenius Medical Care AG & Co. KG (FMC). The issuing companies are FMC Finance VII S,A., FMC Finance VIII S.A., Fresenius Medical Care US Finance II, Inc. and Fresenius Medical Care US Finance, Inc. The senior unsecured ratings are in line with FMC's Long-Term Issuer Default Rating (IDR) of

May 25 2017

Swiss stocks - Factors to watch on May 16

ZURICH, May 16 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,099 points on Tuesday, according to premarket indications by bank Julius Baer .

May 16 2017

Earnings vs. Estimates